Literature DB >> 10192939

Three-dimensional quantitative structure-activity relationship (QSAR) and receptor mapping of cytochrome P-450(14 alpha DM) inhibiting azole antifungal agents.

T T Talele1, V M Kulkarni.   

Abstract

Molecular modeling was performed by a combined use of conformational analysis and 3D-QSAR methods to distinguish structural attributes common to a series of azole antifungal agents. Apex-3D program was used to recognize the common biophoric structural patterns of 13 diverse sets of azole antifungal compounds demonstrating different magnitudes of biological activity. Apex-3D identified three common biophoric features significant for activity: N1 atom of azole ring, the aromatic ring centroid 1, and aromatic ring centroid 2. A common biophore model proposed from the Apex-3D analysis can be useful for the design of novel cytochrome P-450(14 alpha DM) inhibiting antifungal agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192939     DOI: 10.1021/ci9800413

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  4 in total

Review 1.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

2.  Molecular electrostatic potentials as input for the alignment of HIV-1 integrase inhibitors in 3D QSAR.

Authors:  M T Makhija; V M Kulkarni
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

3.  Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.

Authors:  Takashi Fukuoka; Douglas A Johnston; Carol A Winslow; Marcel J de Groot; Catherine Burt; Christopher A Hitchcock; Scott G Filler
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 4.  Conazoles.

Authors:  Jan Heeres; Lieven Meerpoel; Paul Lewi
Journal:  Molecules       Date:  2010-06-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.